Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor - Optimize Trial

NCT01113372 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

3119

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Clopidogrel

Sponsor

Cardiovascular Research Center, Brazil

Collaborators

[object Object]